Companies 0 See All
Hedge Funds 0 See All
Insiders 0 See All
Institutional Investors 0 See All
Click here to see all results for
Home > Insider Trading > Filing (0001209191-19-012245)

Filing Details

Accession Number:
0001209191-19-012245
Form Type:
4
Zero Holdings:
No
Publication Time:
2019-02-21 18:05:39
Reporting Period:
2019-02-19
Accepted Time:
2019-02-21 18:05:39
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1750019 Tcr2 Therapeutics Inc. TCRR Biological Products, (No Disgnostic Substances) (2836) 474152751
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1765022 Mpm Sunstates Fund, L.p. C/O Mpm Capital
450 Kendall Street
Cambridge MA 02142		 No No Yes No
1765023 Mpm Sunstates Gp Managing Member Llc Mpm Capital
450 Kendall Street
Cambridge MA 02142		 No No Yes No
1765025 Mpm Asset Management Investors Sunstates Fund Llc C/O Mpm Capital
450 Kendall Street
Cambridge MA 02142		 No No Yes No
1765026 Mpm Sunstates Fund Gp Llc C/O Mpm Capital
450 Kendall Street
Cambridge MA 02142		 No No Yes No
Reported Non-Derivative Transactions
Show Other Fields >>
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2019-02-19 2,825,396 $0.00 3,021,298 No 4 C Indirect See Footnote
Common Stock Acquisiton 2019-02-19 322,901 $0.00 3,344,199 No 4 C Indirect See Footnote
Common Stock Acquisiton 2019-02-19 706,666 $15.00 4,050,865 No 4 P Indirect See Footnote
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 C Indirect See Footnote
No 4 C Indirect See Footnote
No 4 P Indirect See Footnote
Reported Derivative Transactions
Show Other Fields >>
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Series A Preferred Stock Disposition 2019-02-19 17,500,000 $0.00 2,825,396 $0.00
Common Stock Series B Preferred Stock Disposition 2019-02-19 2,000,000 $0.00 322,901 $0.00
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
0 No 4 C Indirect
0 No 4 C Indirect
Footnotes
  1. All shares of Series A Preferred Stock and Series B Preferred Stock automatically converted into the number of shares of the Issuer's common stock on a 6.1938:1 basis, for no additional consideration, immediately prior to the closing of the Issuer's initial public offering and had no expiration date.
  2. The Reporting Persons disclaim beneficial ownership of the securities except to the extent of their respective pecuniary interests therein.
  3. The shares are held as follows: 2,195,681 by MPM BioVentures 2014, L.P. ("BV 2014"), 146,447 by MPM BioVentures 2014(B), L.P. ("BV 2014(B)"), 79,644 by MPM Asset Management Investors BV2014 LLC ("AM BV2014"), 195,902 by MPM Asset Management LLC ("AM LLC"), 351,155 by MPM SunStates Fund, L.P. ("MPM SunStates") and 52,469 by MPM Asset Management Investors Sunstates Fund LLC ("AM SunStates"). MPM BioVentures 2014 GP LLC and MPM BioVentures 2014 LLC ("BV LLC") are the direct and indirect general partners of BV 2014 and BV 2014(B). MPM SunStates Fund GP LLC and MPM SunStates GP Managing Member LLC ("SunStates GP") are the direct and indirect general partners of MPM SunStates. Luke Evnin, Ansbert Gadicke and Todd Foley are the managing directors of BV LLC, Ansbert Gadicke is a member of SunStates GP and Luke Evnin and Anbsert Gadicke are the members of AM LLC.
  4. The shares are held as follows: 2,451,844 by BV 2014, 163,532 by BV 2014(B), 88,935 by AM BV2014, 195,902 by AM LLC, 386,270 by MPM SunStates and 57,716 by AM SunStates.
  5. The shares are held as follows: 3,056,272 by BV 2014, 203,846 by BV 2014(B), 110,859 by AM BV2014, 195,902 by AM LLC, 421,070 by MPM SunStates and 62,916 by AM SunStates.
  6. No securities held by the Reporting Persons.